GYRE THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Gyre Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Gyre Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.1M.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.1M Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $359K +$342K +2012% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $489K -$177K -26.6% Dec 31, 2023 10-Q 2024-08-13
Q1 2023 $17K -$2.23M -99.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $666K -$2.08M -75.7% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $481K -$2.13M -81.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.73M -$1.37M -44.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $2.24M +$596K +36.2% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.74M +$912K +49.8% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.61M +$1.09M +71.5% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $3.11M +$1.45M +87.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.65M -$149K -8.3% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.83M -$95K -4.93% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.52M -$534K -25.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.66M -$528K -24.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.8M -$520K -22.5% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $1.93M Dec 31, 2019 10-K 2021-03-04
Q3 2019 $2.06M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $2.19M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $2.32M Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.